+ Watch NWBO
on My Watchlist
likely lower & soon
Might be early here, but I'd rather get in my underperform now than miss the inevitable crash and burn.
Work in biotech for 36 yrs and know until phase 3 shows efficacy chances of success are low. However, positive results in phase 2 trials especially with brain cancer is worth the role of the dice. Don't bet the bank, 100 or 200 shares is not too expensive for a potentially significant gain.
Brain, prostate, ovarian cancer vaccines are in late trials.
losing money every quarter, that $1.98M in cash is not going to last much longer...
Just bought some with real money,Great cancer vaccine!
Dr. Leo Spaceman: Now this is surgery, so don't eat anything before you come in. Because I'll have a big breakfast waiting for you.
Reverse split wont keep this stock from crashing.
Technology two decades in the making reaching maturity in the next 24months
Another PR Pump and Dump.
The advantages over DNDN are dramatic. It's just a matter of time.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions